img

Global Orexin Receptor Antagonists Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Orexin Receptor Antagonists Market Insights, Forecast to 2034

Orexin receptor antagonists are the type of therapeutics used in the treatment of sleep disorders, characterized by difficulties or problems with sleep onset. It either bind or inhibits the action of orexin receptor. Orexin plays a vital role in the sleep–wake cycle through a complex interplay between the monoaminergic/cholinergic (wake-promoting) and gamma-aminobutyric acidergic (sleep-promoting) neuronal systems.
Global Orexin Receptor Antagonists market is expected to reach to US$ 4801 million in 2024, with a positive growth of %, compared with US$ 4521 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Orexin Receptor Antagonists industry is evaluated to reach US$ 6887.8 million in 2029. The CAGR will be 6.2% during 2024 to 2029.
Increased prevalence of various sleep disorders such as insomnia and parasomnias, along with rising incidence of depression and other distressing disorders are major factors driving insomnia. Expanding the Global Insomnia Market. Sleep disturbance is a common symptom of depression. For example, according to the World Health Organization (WHO), approximately 280 million people worldwide suffer from depression. Hence, the surge in the prevalence of psychotic depression across the world has led to the expansion of the insomnia market. In addition, long-term use of a drug to treat a chronic condition may cause certain adverse effects, some of which are thought to impair a patient's ability to get a good night's sleep. This means that the expansion of the market is driven by the increasing prevalence of chronic diseases such as cancer.
Report Covers
This report presents an overview of global Orexin Receptor Antagonists market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Orexin Receptor Antagonists market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Eisai Co., Ltd
Sun Pharmaceutical Industries Ltd
Novartis AG
Endo Pharmaceuticals plc
Mylan NV
Cereve Inc.
Teva Pharmaceutical Industries Ltd
Amneal Pharmaceuticals Inc
Merck & Co.
Sanofi
Currax Pharmaceuticals LLC
Pfizer Inc.
Segment by Type
Oral
Parenteral

Segment by Application


Insomnia
Anxious
Other

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Orexin Receptor Antagonists plant distribution, commercial date of Orexin Receptor Antagonists, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Orexin Receptor Antagonists introduction, etc. Orexin Receptor Antagonists Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Orexin Receptor Antagonists
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Orexin Receptor Antagonists Product Introduction
1.2 Market by Type
1.2.1 Global Orexin Receptor Antagonists Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Oral
1.2.3 Parenteral
1.3 Market by Application
1.3.1 Global Orexin Receptor Antagonists Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Insomnia
1.3.3 Anxious
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Orexin Receptor Antagonists Sales Estimates and Forecasts 2018-2029
2.2 Global Orexin Receptor Antagonists Revenue by Region
2.2.1 Global Orexin Receptor Antagonists Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Orexin Receptor Antagonists Revenue by Region (2018-2024)
2.2.3 Global Orexin Receptor Antagonists Revenue by Region (2024-2029)
2.2.4 Global Orexin Receptor Antagonists Revenue Market Share by Region (2018-2029)
2.3 Global Orexin Receptor Antagonists Sales Estimates and Forecasts 2018-2029
2.4 Global Orexin Receptor Antagonists Sales by Region
2.4.1 Global Orexin Receptor Antagonists Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Orexin Receptor Antagonists Sales by Region (2018-2024)
2.4.3 Global Orexin Receptor Antagonists Sales by Region (2024-2029)
2.4.4 Global Orexin Receptor Antagonists Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Orexin Receptor Antagonists Sales by Manufacturers
3.1.1 Global Orexin Receptor Antagonists Sales by Manufacturers (2018-2024)
3.1.2 Global Orexin Receptor Antagonists Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Orexin Receptor Antagonists in 2022
3.2 Global Orexin Receptor Antagonists Revenue by Manufacturers
3.2.1 Global Orexin Receptor Antagonists Revenue by Manufacturers (2018-2024)
3.2.2 Global Orexin Receptor Antagonists Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Orexin Receptor Antagonists Revenue in 2022
3.3 Global Key Players of Orexin Receptor Antagonists, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Orexin Receptor Antagonists Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Orexin Receptor Antagonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Orexin Receptor Antagonists, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Orexin Receptor Antagonists, Product Offered and Application
3.8 Global Key Manufacturers of Orexin Receptor Antagonists, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Orexin Receptor Antagonists Sales by Type
4.1.1 Global Orexin Receptor Antagonists Historical Sales by Type (2018-2024)
4.1.2 Global Orexin Receptor Antagonists Forecasted Sales by Type (2024-2029)
4.1.3 Global Orexin Receptor Antagonists Sales Market Share by Type (2018-2029)
4.2 Global Orexin Receptor Antagonists Revenue by Type
4.2.1 Global Orexin Receptor Antagonists Historical Revenue by Type (2018-2024)
4.2.2 Global Orexin Receptor Antagonists Forecasted Revenue by Type (2024-2029)
4.2.3 Global Orexin Receptor Antagonists Revenue Market Share by Type (2018-2029)
4.3 Global Orexin Receptor Antagonists Price by Type
4.3.1 Global Orexin Receptor Antagonists Price by Type (2018-2024)
4.3.2 Global Orexin Receptor Antagonists Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Orexin Receptor Antagonists Sales by Application
5.1.1 Global Orexin Receptor Antagonists Historical Sales by Application (2018-2024)
5.1.2 Global Orexin Receptor Antagonists Forecasted Sales by Application (2024-2029)
5.1.3 Global Orexin Receptor Antagonists Sales Market Share by Application (2018-2029)
5.2 Global Orexin Receptor Antagonists Revenue by Application
5.2.1 Global Orexin Receptor Antagonists Historical Revenue by Application (2018-2024)
5.2.2 Global Orexin Receptor Antagonists Forecasted Revenue by Application (2024-2029)
5.2.3 Global Orexin Receptor Antagonists Revenue Market Share by Application (2018-2029)
5.3 Global Orexin Receptor Antagonists Price by Application
5.3.1 Global Orexin Receptor Antagonists Price by Application (2018-2024)
5.3.2 Global Orexin Receptor Antagonists Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Orexin Receptor Antagonists Market Size by Type
6.1.1 US & Canada Orexin Receptor Antagonists Sales by Type (2018-2029)
6.1.2 US & Canada Orexin Receptor Antagonists Revenue by Type (2018-2029)
6.2 US & Canada Orexin Receptor Antagonists Market Size by Application
6.2.1 US & Canada Orexin Receptor Antagonists Sales by Application (2018-2029)
6.2.2 US & Canada Orexin Receptor Antagonists Revenue by Application (2018-2029)
6.3 US & Canada Orexin Receptor Antagonists Market Size by Country
6.3.1 US & Canada Orexin Receptor Antagonists Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Orexin Receptor Antagonists Sales by Country (2018-2029)
6.3.3 US & Canada Orexin Receptor Antagonists Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Orexin Receptor Antagonists Market Size by Type
7.1.1 Europe Orexin Receptor Antagonists Sales by Type (2018-2029)
7.1.2 Europe Orexin Receptor Antagonists Revenue by Type (2018-2029)
7.2 Europe Orexin Receptor Antagonists Market Size by Application
7.2.1 Europe Orexin Receptor Antagonists Sales by Application (2018-2029)
7.2.2 Europe Orexin Receptor Antagonists Revenue by Application (2018-2029)
7.3 Europe Orexin Receptor Antagonists Market Size by Country
7.3.1 Europe Orexin Receptor Antagonists Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Orexin Receptor Antagonists Sales by Country (2018-2029)
7.3.3 Europe Orexin Receptor Antagonists Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Orexin Receptor Antagonists Market Size
8.1.1 China Orexin Receptor Antagonists Sales (2018-2029)
8.1.2 China Orexin Receptor Antagonists Revenue (2018-2029)
8.2 China Orexin Receptor Antagonists Market Size by Application
8.2.1 China Orexin Receptor Antagonists Sales by Application (2018-2029)
8.2.2 China Orexin Receptor Antagonists Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Orexin Receptor Antagonists Market Size by Type
9.1.1 Asia Orexin Receptor Antagonists Sales by Type (2018-2029)
9.1.2 Asia Orexin Receptor Antagonists Revenue by Type (2018-2029)
9.2 Asia Orexin Receptor Antagonists Market Size by Application
9.2.1 Asia Orexin Receptor Antagonists Sales by Application (2018-2029)
9.2.2 Asia Orexin Receptor Antagonists Revenue by Application (2018-2029)
9.3 Asia Orexin Receptor Antagonists Sales by Region
9.3.1 Asia Orexin Receptor Antagonists Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Orexin Receptor Antagonists Revenue by Region (2018-2029)
9.3.3 Asia Orexin Receptor Antagonists Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Orexin Receptor Antagonists Market Size by Type
10.1.1 Middle East, Africa and Latin America Orexin Receptor Antagonists Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Orexin Receptor Antagonists Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Orexin Receptor Antagonists Market Size by Application
10.2.1 Middle East, Africa and Latin America Orexin Receptor Antagonists Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Orexin Receptor Antagonists Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Orexin Receptor Antagonists Sales by Country
10.3.1 Middle East, Africa and Latin America Orexin Receptor Antagonists Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Orexin Receptor Antagonists Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Orexin Receptor Antagonists Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Eisai Co., Ltd
11.1.1 Eisai Co., Ltd Company Information
11.1.2 Eisai Co., Ltd Overview
11.1.3 Eisai Co., Ltd Orexin Receptor Antagonists Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Eisai Co., Ltd Orexin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Eisai Co., Ltd Recent Developments
11.2 Sun Pharmaceutical Industries Ltd
11.2.1 Sun Pharmaceutical Industries Ltd Company Information
11.2.2 Sun Pharmaceutical Industries Ltd Overview
11.2.3 Sun Pharmaceutical Industries Ltd Orexin Receptor Antagonists Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Sun Pharmaceutical Industries Ltd Orexin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Sun Pharmaceutical Industries Ltd Recent Developments
11.3 Novartis AG
11.3.1 Novartis AG Company Information
11.3.2 Novartis AG Overview
11.3.3 Novartis AG Orexin Receptor Antagonists Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Novartis AG Orexin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Novartis AG Recent Developments
11.4 Endo Pharmaceuticals plc
11.4.1 Endo Pharmaceuticals plc Company Information
11.4.2 Endo Pharmaceuticals plc Overview
11.4.3 Endo Pharmaceuticals plc Orexin Receptor Antagonists Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Endo Pharmaceuticals plc Orexin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Endo Pharmaceuticals plc Recent Developments
11.5 Mylan NV
11.5.1 Mylan NV Company Information
11.5.2 Mylan NV Overview
11.5.3 Mylan NV Orexin Receptor Antagonists Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Mylan NV Orexin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Mylan NV Recent Developments
11.6 Cereve Inc.
11.6.1 Cereve Inc. Company Information
11.6.2 Cereve Inc. Overview
11.6.3 Cereve Inc. Orexin Receptor Antagonists Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Cereve Inc. Orexin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Cereve Inc. Recent Developments
11.7 Teva Pharmaceutical Industries Ltd
11.7.1 Teva Pharmaceutical Industries Ltd Company Information
11.7.2 Teva Pharmaceutical Industries Ltd Overview
11.7.3 Teva Pharmaceutical Industries Ltd Orexin Receptor Antagonists Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Teva Pharmaceutical Industries Ltd Orexin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Teva Pharmaceutical Industries Ltd Recent Developments
11.8 Amneal Pharmaceuticals Inc
11.8.1 Amneal Pharmaceuticals Inc Company Information
11.8.2 Amneal Pharmaceuticals Inc Overview
11.8.3 Amneal Pharmaceuticals Inc Orexin Receptor Antagonists Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Amneal Pharmaceuticals Inc Orexin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Amneal Pharmaceuticals Inc Recent Developments
11.9 Merck & Co.
11.9.1 Merck & Co. Company Information
11.9.2 Merck & Co. Overview
11.9.3 Merck & Co. Orexin Receptor Antagonists Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Merck & Co. Orexin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Merck & Co. Recent Developments
11.10 Sanofi
11.10.1 Sanofi Company Information
11.10.2 Sanofi Overview
11.10.3 Sanofi Orexin Receptor Antagonists Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Sanofi Orexin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Sanofi Recent Developments
11.11 Currax Pharmaceuticals LLC
11.11.1 Currax Pharmaceuticals LLC Company Information
11.11.2 Currax Pharmaceuticals LLC Overview
11.11.3 Currax Pharmaceuticals LLC Orexin Receptor Antagonists Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Currax Pharmaceuticals LLC Orexin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Currax Pharmaceuticals LLC Recent Developments
11.12 Pfizer Inc.
11.12.1 Pfizer Inc. Company Information
11.12.2 Pfizer Inc. Overview
11.12.3 Pfizer Inc. Orexin Receptor Antagonists Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Pfizer Inc. Orexin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Pfizer Inc. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Orexin Receptor Antagonists Industry Chain Analysis
12.2 Orexin Receptor Antagonists Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Orexin Receptor Antagonists Production Mode & Process
12.4 Orexin Receptor Antagonists Sales and Marketing
12.4.1 Orexin Receptor Antagonists Sales Channels
12.4.2 Orexin Receptor Antagonists Distributors
12.5 Orexin Receptor Antagonists Customers
13 Market Dynamics
13.1 Orexin Receptor Antagonists Industry Trends
13.2 Orexin Receptor Antagonists Market Drivers
13.3 Orexin Receptor Antagonists Market Challenges
13.4 Orexin Receptor Antagonists Market Restraints
14 Key Findings in The Global Orexin Receptor Antagonists Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Orexin Receptor Antagonists Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Oral
Table 3. Major Manufacturers of Parenteral
Table 4. Global Orexin Receptor Antagonists Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Orexin Receptor Antagonists Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Orexin Receptor Antagonists Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Orexin Receptor Antagonists Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Orexin Receptor Antagonists Revenue Market Share by Region (2018-2024)
Table 9. Global Orexin Receptor Antagonists Revenue Market Share by Region (2024-2029)
Table 10. Global Orexin Receptor Antagonists Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Orexin Receptor Antagonists Sales by Region (2018-2024) & (K Units)
Table 12. Global Orexin Receptor Antagonists Sales by Region (2024-2029) & (K Units)
Table 13. Global Orexin Receptor Antagonists Sales Market Share by Region (2018-2024)
Table 14. Global Orexin Receptor Antagonists Sales Market Share by Region (2024-2029)
Table 15. Global Orexin Receptor Antagonists Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Orexin Receptor Antagonists Sales Share by Manufacturers (2018-2024)
Table 17. Global Orexin Receptor Antagonists Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Orexin Receptor Antagonists Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Orexin Receptor Antagonists, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Orexin Receptor Antagonists Price by Manufacturers 2018-2024 (US$/Unit)
Table 21. Global Orexin Receptor Antagonists Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Orexin Receptor Antagonists by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Orexin Receptor Antagonists as of 2022)
Table 23. Global Key Manufacturers of Orexin Receptor Antagonists, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Orexin Receptor Antagonists, Product Offered and Application
Table 25. Global Key Manufacturers of Orexin Receptor Antagonists, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Orexin Receptor Antagonists Sales by Type (2018-2024) & (K Units)
Table 28. Global Orexin Receptor Antagonists Sales by Type (2024-2029) & (K Units)
Table 29. Global Orexin Receptor Antagonists Sales Share by Type (2018-2024)
Table 30. Global Orexin Receptor Antagonists Sales Share by Type (2024-2029)
Table 31. Global Orexin Receptor Antagonists Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Orexin Receptor Antagonists Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Orexin Receptor Antagonists Revenue Share by Type (2018-2024)
Table 34. Global Orexin Receptor Antagonists Revenue Share by Type (2024-2029)
Table 35. Orexin Receptor Antagonists Price by Type (2018-2024) & (US$/Unit)
Table 36. Global Orexin Receptor Antagonists Price Forecast by Type (2024-2029) & (US$/Unit)
Table 37. Global Orexin Receptor Antagonists Sales by Application (2018-2024) & (K Units)
Table 38. Global Orexin Receptor Antagonists Sales by Application (2024-2029) & (K Units)
Table 39. Global Orexin Receptor Antagonists Sales Share by Application (2018-2024)
Table 40. Global Orexin Receptor Antagonists Sales Share by Application (2024-2029)
Table 41. Global Orexin Receptor Antagonists Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Orexin Receptor Antagonists Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Orexin Receptor Antagonists Revenue Share by Application (2018-2024)
Table 44. Global Orexin Receptor Antagonists Revenue Share by Application (2024-2029)
Table 45. Orexin Receptor Antagonists Price by Application (2018-2024) & (US$/Unit)
Table 46. Global Orexin Receptor Antagonists Price Forecast by Application (2024-2029) & (US$/Unit)
Table 47. US & Canada Orexin Receptor Antagonists Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Orexin Receptor Antagonists Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Orexin Receptor Antagonists Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Orexin Receptor Antagonists Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Orexin Receptor Antagonists Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Orexin Receptor Antagonists Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Orexin Receptor Antagonists Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Orexin Receptor Antagonists Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Orexin Receptor Antagonists Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Orexin Receptor Antagonists Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Orexin Receptor Antagonists Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Orexin Receptor Antagonists Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Orexin Receptor Antagonists Sales by Country (2024-2029) & (K Units)
Table 60. Europe Orexin Receptor Antagonists Sales by Type (2018-2024) & (K Units)
Table 61. Europe Orexin Receptor Antagonists Sales by Type (2024-2029) & (K Units)
Table 62. Europe Orexin Receptor Antagonists Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Orexin Receptor Antagonists Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Orexin Receptor Antagonists Sales by Application (2018-2024) & (K Units)
Table 65. Europe Orexin Receptor Antagonists Sales by Application (2024-2029) & (K Units)
Table 66. Europe Orexin Receptor Antagonists Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Orexin Receptor Antagonists Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Orexin Receptor Antagonists Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Orexin Receptor Antagonists Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Orexin Receptor Antagonists Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Orexin Receptor Antagonists Sales by Country (2018-2024) & (K Units)
Table 72. Europe Orexin Receptor Antagonists Sales by Country (2024-2029) & (K Units)
Table 73. China Orexin Receptor Antagonists Sales by Type (2018-2024) & (K Units)
Table 74. China Orexin Receptor Antagonists Sales by Type (2024-2029) & (K Units)
Table 75. China Orexin Receptor Antagonists Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Orexin Receptor Antagonists Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Orexin Receptor Antagonists Sales by Application (2018-2024) & (K Units)
Table 78. China Orexin Receptor Antagonists Sales by Application (2024-2029) & (K Units)
Table 79. China Orexin Receptor Antagonists Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Orexin Receptor Antagonists Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Orexin Receptor Antagonists Sales by Type (2018-2024) & (K Units)
Table 82. Asia Orexin Receptor Antagonists Sales by Type (2024-2029) & (K Units)
Table 83. Asia Orexin Receptor Antagonists Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Orexin Receptor Antagonists Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Orexin Receptor Antagonists Sales by Application (2018-2024) & (K Units)
Table 86. Asia Orexin Receptor Antagonists Sales by Application (2024-2029) & (K Units)
Table 87. Asia Orexin Receptor Antagonists Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Orexin Receptor Antagonists Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Orexin Receptor Antagonists Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Orexin Receptor Antagonists Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Orexin Receptor Antagonists Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Orexin Receptor Antagonists Sales by Region (2018-2024) & (K Units)
Table 93. Asia Orexin Receptor Antagonists Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Orexin Receptor Antagonists Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Orexin Receptor Antagonists Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Orexin Receptor Antagonists Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Orexin Receptor Antagonists Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Orexin Receptor Antagonists Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Orexin Receptor Antagonists Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Orexin Receptor Antagonists Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Orexin Receptor Antagonists Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Orexin Receptor Antagonists Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Orexin Receptor Antagonists Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Orexin Receptor Antagonists Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Orexin Receptor Antagonists Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Orexin Receptor Antagonists Sales by Country (2024-2029) & (K Units)
Table 107. Eisai Co., Ltd Company Information
Table 108. Eisai Co., Ltd Description and Major Businesses
Table 109. Eisai Co., Ltd Orexin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Eisai Co., Ltd Orexin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Eisai Co., Ltd Recent Developments
Table 112. Sun Pharmaceutical Industries Ltd Company Information
Table 113. Sun Pharmaceutical Industries Ltd Description and Major Businesses
Table 114. Sun Pharmaceutical Industries Ltd Orexin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. Sun Pharmaceutical Industries Ltd Orexin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Sun Pharmaceutical Industries Ltd Recent Developments
Table 117. Novartis AG Company Information
Table 118. Novartis AG Description and Major Businesses
Table 119. Novartis AG Orexin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Novartis AG Orexin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Novartis AG Recent Developments
Table 122. Endo Pharmaceuticals plc Company Information
Table 123. Endo Pharmaceuticals plc Description and Major Businesses
Table 124. Endo Pharmaceuticals plc Orexin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Endo Pharmaceuticals plc Orexin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Endo Pharmaceuticals plc Recent Developments
Table 127. Mylan NV Company Information
Table 128. Mylan NV Description and Major Businesses
Table 129. Mylan NV Orexin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. Mylan NV Orexin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Mylan NV Recent Developments
Table 132. Cereve Inc. Company Information
Table 133. Cereve Inc. Description and Major Businesses
Table 134. Cereve Inc. Orexin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. Cereve Inc. Orexin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Cereve Inc. Recent Developments
Table 137. Teva Pharmaceutical Industries Ltd Company Information
Table 138. Teva Pharmaceutical Industries Ltd Description and Major Businesses
Table 139. Teva Pharmaceutical Industries Ltd Orexin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. Teva Pharmaceutical Industries Ltd Orexin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Teva Pharmaceutical Industries Ltd Recent Developments
Table 142. Amneal Pharmaceuticals Inc Company Information
Table 143. Amneal Pharmaceuticals Inc Description and Major Businesses
Table 144. Amneal Pharmaceuticals Inc Orexin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. Amneal Pharmaceuticals Inc Orexin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Amneal Pharmaceuticals Inc Recent Developments
Table 147. Merck & Co. Company Information
Table 148. Merck & Co. Description and Major Businesses
Table 149. Merck & Co. Orexin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 150. Merck & Co. Orexin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Merck & Co. Recent Developments
Table 152. Sanofi Company Information
Table 153. Sanofi Description and Major Businesses
Table 154. Sanofi Orexin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 155. Sanofi Orexin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Sanofi Recent Developments
Table 157. Currax Pharmaceuticals LLC Company Information
Table 158. Currax Pharmaceuticals LLC Description and Major Businesses
Table 159. Currax Pharmaceuticals LLC Orexin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 160. Currax Pharmaceuticals LLC Orexin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Currax Pharmaceuticals LLC Recent Developments
Table 162. Pfizer Inc. Company Information
Table 163. Pfizer Inc. Description and Major Businesses
Table 164. Pfizer Inc. Orexin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 165. Pfizer Inc. Orexin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Pfizer Inc. Recent Developments
Table 167. Key Raw Materials Lists
Table 168. Raw Materials Key Suppliers Lists
Table 169. Orexin Receptor Antagonists Distributors List
Table 170. Orexin Receptor Antagonists Customers List
Table 171. Orexin Receptor Antagonists Market Trends
Table 172. Orexin Receptor Antagonists Market Drivers
Table 173. Orexin Receptor Antagonists Market Challenges
Table 174. Orexin Receptor Antagonists Market Restraints
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. Orexin Receptor Antagonists Product Picture
Figure 2. Global Orexin Receptor Antagonists Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Orexin Receptor Antagonists Market Share by Type in 2022 & 2029
Figure 4. Oral Product Picture
Figure 5. Parenteral Product Picture
Figure 6. Global Orexin Receptor Antagonists Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Orexin Receptor Antagonists Market Share by Application in 2022 & 2029
Figure 8. Insomnia
Figure 9. Anxious
Figure 10. Other
Figure 11. Orexin Receptor Antagonists Report Years Considered
Figure 12. Global Orexin Receptor Antagonists Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Orexin Receptor Antagonists Revenue 2018-2029 (US$ Million)
Figure 14. Global Orexin Receptor Antagonists Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 15. Global Orexin Receptor Antagonists Revenue Market Share by Region (2018-2029)
Figure 16. Global Orexin Receptor Antagonists Sales 2018-2029 ((K Units)
Figure 17. Global Orexin Receptor Antagonists Sales Market Share by Region (2018-2029)
Figure 18. US & Canada Orexin Receptor Antagonists Sales YoY (2018-2029) & (K Units)
Figure 19. US & Canada Orexin Receptor Antagonists Revenue YoY (2018-2029) & (US$ Million)
Figure 20. Europe Orexin Receptor Antagonists Sales YoY (2018-2029) & (K Units)
Figure 21. Europe Orexin Receptor Antagonists Revenue YoY (2018-2029) & (US$ Million)
Figure 22. China Orexin Receptor Antagonists Sales YoY (2018-2029) & (K Units)
Figure 23. China Orexin Receptor Antagonists Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Asia (excluding China) Orexin Receptor Antagonists Sales YoY (2018-2029) & (K Units)
Figure 25. Asia (excluding China) Orexin Receptor Antagonists Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Orexin Receptor Antagonists Sales YoY (2018-2029) & (K Units)
Figure 27. Middle East, Africa and Latin America Orexin Receptor Antagonists Revenue YoY (2018-2029) & (US$ Million)
Figure 28. The Orexin Receptor Antagonists Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 29. The Top 5 and 10 Largest Manufacturers of Orexin Receptor Antagonists in the World: Market Share by Orexin Receptor Antagonists Revenue in 2022
Figure 30. Global Orexin Receptor Antagonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Orexin Receptor Antagonists Sales Market Share by Type (2018-2029)
Figure 32. Global Orexin Receptor Antagonists Revenue Market Share by Type (2018-2029)
Figure 33. Global Orexin Receptor Antagonists Sales Market Share by Application (2018-2029)
Figure 34. Global Orexin Receptor Antagonists Revenue Market Share by Application (2018-2029)
Figure 35. US & Canada Orexin Receptor Antagonists Sales Market Share by Type (2018-2029)
Figure 36. US & Canada Orexin Receptor Antagonists Revenue Market Share by Type (2018-2029)
Figure 37. US & Canada Orexin Receptor Antagonists Sales Market Share by Application (2018-2029)
Figure 38. US & Canada Orexin Receptor Antagonists Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada Orexin Receptor Antagonists Revenue Share by Country (2018-2029)
Figure 40. US & Canada Orexin Receptor Antagonists Sales Share by Country (2018-2029)
Figure 41. U.S. Orexin Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 42. Canada Orexin Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 43. Europe Orexin Receptor Antagonists Sales Market Share by Type (2018-2029)
Figure 44. Europe Orexin Receptor Antagonists Revenue Market Share by Type (2018-2029)
Figure 45. Europe Orexin Receptor Antagonists Sales Market Share by Application (2018-2029)
Figure 46. Europe Orexin Receptor Antagonists Revenue Market Share by Application (2018-2029)
Figure 47. Europe Orexin Receptor Antagonists Revenue Share by Country (2018-2029)
Figure 48. Europe Orexin Receptor Antagonists Sales Share by Country (2018-2029)
Figure 49. Germany Orexin Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 50. France Orexin Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 51. U.K. Orexin Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 52. Italy Orexin Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 53. Russia Orexin Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 54. China Orexin Receptor Antagonists Sales Market Share by Type (2018-2029)
Figure 55. China Orexin Receptor Antagonists Revenue Market Share by Type (2018-2029)
Figure 56. China Orexin Receptor Antagonists Sales Market Share by Application (2018-2029)
Figure 57. China Orexin Receptor Antagonists Revenue Market Share by Application (2018-2029)
Figure 58. Asia Orexin Receptor Antagonists Sales Market Share by Type (2018-2029)
Figure 59. Asia Orexin Receptor Antagonists Revenue Market Share by Type (2018-2029)
Figure 60. Asia Orexin Receptor Antagonists Sales Market Share by Application (2018-2029)
Figure 61. Asia Orexin Receptor Antagonists Revenue Market Share by Application (2018-2029)
Figure 62. Asia Orexin Receptor Antagonists Revenue Share by Region (2018-2029)
Figure 63. Asia Orexin Receptor Antagonists Sales Share by Region (2018-2029)
Figure 64. Japan Orexin Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 65. South Korea Orexin Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 66. China Taiwan Orexin Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 67. Southeast Asia Orexin Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 68. India Orexin Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Orexin Receptor Antagonists Sales Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Orexin Receptor Antagonists Revenue Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Orexin Receptor Antagonists Sales Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Orexin Receptor Antagonists Revenue Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Orexin Receptor Antagonists Revenue Share by Country (2018-2029)
Figure 74. Middle East, Africa and Latin America Orexin Receptor Antagonists Sales Share by Country (2018-2029)
Figure 75. Brazil Orexin Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 76. Mexico Orexin Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 77. Turkey Orexin Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 78. Israel Orexin Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 79. GCC Countries Orexin Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 80. Orexin Receptor Antagonists Value Chain
Figure 81. Orexin Receptor Antagonists Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries